Director, Clinical Development
Tonix Pharmaceuticals
Director, Clinical Development
Tonix Pharmaceuticals
Clinical-stage biopharma in CNS and vaccines
Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix’s CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti-Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X.
*Tonix’s product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication.
Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners.
Position Overview
The Director, Clinical Development provides medical and scientific leadership across clinical development programs, supporting the design, execution, and oversight of clinical trials from Phase 1 through Phase 3. This role combines strategic clinical development responsibilities with hands-on medical monitoring to ensure patient safety, scientific integrity, regulatory compliance, and high-quality clinical data.
The Director serves as the primary Medical Monitor for assigned studies, providing timely medical guidance to investigators, clinical sites, CROs, and internal study teams. Working closely with Clinical Operations, Pharmacovigilance, Biostatistics, Data Management, Regulatory Affairs, and other cross-functional partners, this individual contributes to clinical development strategy while maintaining direct involvement in study execution, safety oversight, and emerging clinical data.
Guided by Tonix's core values of integrity, commitment, innovation, and passion, the Director applies sound clinical judgment, scientific expertise, and collaborative leadership to advance development programs and support the delivery of innovative therapies to patients.
Key Responsibilities
Clinical Development and Study Strategy
Medical Monitoring and Patient Safety
Regulatory and Scientific Activities
Cross-Functional Collaboration and Leadership
Qualifications
*Please note that Tonix does not offer sponsorship for this role.
Recruitment & Staffing Agencies
Tonix does not accept agency resumes unless contacted directly by internal Tonix Talent Acquisition. Please do not forward resumes to Tonix employees or any other company location; Tonix is not responsible for any fees related to unsolicited resumes.
Compensation & Benefits
Tonix provides a comprehensive compensation and benefits package which includes:
Tonix provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, sex, national origin, age, genetics, or any other characteristic protected by law. In addition to federal law requirements, Tonix complies with applicable state and local laws governing nondiscrimination in employment. This policy applies to all terms and conditions of employment, including recruiting, hiring, placement, promotion, termination, layoff, recall, transfers, leaves of absence, compensation, and training. Tonix expressly prohibits any form of workplace harassment based on race, color, religion, gender, sexual orientation, gender identity or expression, national origin, age, genetic, information, disability, veteran status, or any other characteristic protected by law.
Salary Range 190000 - 240000 USD
Clinical-stage biopharma in CNS and vaccines
Tonix Pharmaceuticals develops therapeutics and biologics for CNS disorders, rare diseases, immunology, and infectious diseases. Its products include Zembrace SymTouch and Tosymra for acute migraine, providing near-term revenue while it advances a pipeline across CNS conditions like fibromyalgia with Tonmya (TNX-102 SL); infectious disease vaccines from a horsepox-based platform led by TNX-801 for smallpox and mpox; and immunology programs for transplant rejection, autoimmunity, and cancer. The company aims to move candidates through clinical trials to regulatory approval and commercialization, using partnerships to grow its long-term portfolio. By mixing established migraine meds with a diversified, research-driven pipeline, Tonix targets recurring revenue now and growth in CNS, infectious disease, and immunology over time.
Explore more opportunities at Tonix Pharmaceuticals